vs

Side-by-side financial comparison of Prelude Therapeutics Inc (PRLD) and Recon Technology, Ltd (RCON). Click either name above to swap in a different company.

Recon Technology, Ltd is the larger business by last-quarter revenue ($12.2M vs $6.5M, roughly 1.9× Prelude Therapeutics Inc). Recon Technology, Ltd runs the higher net margin — -6.8% vs -303.5%, a 296.6% gap on every dollar of revenue. On growth, Prelude Therapeutics Inc posted the faster year-over-year revenue change (116.7% vs 111.0%).

Recon Instruments Inc. was a Canadian technology company that produced smartglasses and wearable displays marketed by the company as "heads-up displays" for sports. Recon's products delivered live activity metrics, GPS maps, and notifications directly to the user's eye. Recon's first heads-up display offering was released commercially in October 2010, roughly a year and a half before Google introduced Google Glass.

PRLD vs RCON — Head-to-Head

Bigger by revenue
RCON
RCON
1.9× larger
RCON
$12.2M
$6.5M
PRLD
Growing faster (revenue YoY)
PRLD
PRLD
+5.7% gap
PRLD
116.7%
111.0%
RCON
Higher net margin
RCON
RCON
296.6% more per $
RCON
-6.8%
-303.5%
PRLD

Income Statement — Q3 FY2025 vs Q2 FY2026

Metric
PRLD
PRLD
RCON
RCON
Revenue
$6.5M
$12.2M
Net Profit
$-19.7M
$-832.7K
Gross Margin
33.5%
Operating Margin
-314.1%
-14.6%
Net Margin
-303.5%
-6.8%
Revenue YoY
116.7%
111.0%
Net Profit YoY
38.9%
70.5%
EPS (diluted)
$-0.26
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRLD
PRLD
RCON
RCON
Q4 25
$12.2M
Q3 25
$6.5M
Q4 24
$5.8M
Q3 24
$3.0M
Q4 23
$6.4M
Net Profit
PRLD
PRLD
RCON
RCON
Q4 25
$-832.7K
Q3 25
$-19.7M
Q4 24
$-2.8M
Q3 24
$-32.3M
Q4 23
$-3.2M
Gross Margin
PRLD
PRLD
RCON
RCON
Q4 25
33.5%
Q3 25
Q4 24
31.7%
Q3 24
Q4 23
26.7%
Operating Margin
PRLD
PRLD
RCON
RCON
Q4 25
-14.6%
Q3 25
-314.1%
Q4 24
-63.9%
Q3 24
-1145.9%
Q4 23
-50.4%
Net Margin
PRLD
PRLD
RCON
RCON
Q4 25
-6.8%
Q3 25
-303.5%
Q4 24
-48.9%
Q3 24
-1075.7%
Q4 23
-49.8%
EPS (diluted)
PRLD
PRLD
RCON
RCON
Q4 25
$-0.09
Q3 25
$-0.26
Q4 24
$-0.31
Q3 24
$-0.43
Q4 23
$-1.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRLD
PRLD
RCON
RCON
Cash + ST InvestmentsLiquidity on hand
$55.0M
$10.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$58.5M
$66.4M
Total Assets
$94.8M
$77.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRLD
PRLD
RCON
RCON
Q4 25
$10.7M
Q3 25
$55.0M
Q4 24
$19.9M
Q3 24
$153.6M
Q4 23
$36.0M
Stockholders' Equity
PRLD
PRLD
RCON
RCON
Q4 25
$66.4M
Q3 25
$58.5M
Q4 24
$66.9M
Q3 24
$156.4M
Q4 23
$60.0M
Total Assets
PRLD
PRLD
RCON
RCON
Q4 25
$77.6M
Q3 25
$94.8M
Q4 24
$74.2M
Q3 24
$197.2M
Q4 23
$68.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRLD
PRLD
RCON
RCON
Operating Cash FlowLast quarter
$-19.1M
$-1.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRLD
PRLD
RCON
RCON
Q4 25
$-1.9M
Q3 25
$-19.1M
Q4 24
$-1.7M
Q3 24
$-27.3M
Q4 23
$-931.0K
Free Cash Flow
PRLD
PRLD
RCON
RCON
Q4 25
Q3 25
Q4 24
Q3 24
$-27.4M
Q4 23
FCF Margin
PRLD
PRLD
RCON
RCON
Q4 25
Q3 25
Q4 24
Q3 24
-912.0%
Q4 23
Capex Intensity
PRLD
PRLD
RCON
RCON
Q4 25
Q3 25
0.0%
Q4 24
Q3 24
2.1%
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons